ONC-206 is a new experimental therapy, related to Onc-201. The first clinical trial of Onc-201 just opened at UCSF for patients with newly diagnosed diffuse midline gliomas or recurrent high grade gliomas.
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com